Preview Citation


Lin, V..G., Nabell, L. M., Spencer, S. A., Carroll, W. R., Harada, S., & Yang, E. S. (2018). First-Line Treatment of Widely Metastatic BRAF-Mutated Salivary Duct Carcinoma With Combined BRAF and MEK Inhibition, Journal of the National Comprehensive Cancer Network J Natl Compr Canc Netw, 16(10), 1166-1170. Retrieved Dec 16, 2019, from